PDF
T/SDHCST 008-2023 Active
Operating Procedures for Immunogenicity and Immunotoxicity Testing of Cell Therapy Products according to T/SDHCST 008-2023
Abstract
Main technical content: This standard specifies the basic requirements for the immunogenicity and immunotoxicity of cell therapy products. This standard is applicable to the evaluation of the immunogenicity and immunotoxicity of cell therapy products.
General Product Information
| Document Type | Group standards |
|---|---|
| Standard Status | Active |
| Standard Code | T/SDHCST 008-2023 |
| ICS | Biology, botany, and zoology |
| Implement Date | 2023-07-28 |
Price
$ 20.00
Subtotal
$ 20.00
Tax
$ 0.00
Order Total (incl. tax)
$ 20.00